东软集团(600718) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,849,804,893, representing a 1.06% increase compared to CNY 1,830,426,473 in the same period last year[2] - The net profit attributable to shareholders of the listed company was a loss of CNY 12,090,412, a decrease of 330.18% from a profit of CNY 5,252,539 in the previous year[2] - The basic and diluted earnings per share were both CNY -0.010, reflecting a decline of 332.28% from CNY 0.004 in the same period last year[2] - The net profit for Q1 2025 was a loss of CNY 14.71 million, compared to a profit of CNY 1.91 million in Q1 2024, indicating a significant downturn[15] - The total comprehensive income for Q1 2025 was CNY 2.04 million, a significant drop from a loss of CNY 20.42 million in Q1 2024[16] - Basic and diluted earnings per share for Q1 2025 were both CNY -0.010, compared to CNY 0.004 in Q1 2024, reflecting a decline in profitability[16] Cash Flow and Liquidity - The net cash flow from operating activities was a negative CNY 539,042,085, compared to a negative CNY 515,678,036 in the previous year[2] - The company's cash and cash equivalents decreased to CNY 2,015,465,916 from CNY 2,790,295,116 at the end of 2024[10] - Cash and cash equivalents at the end of Q1 2025 stood at CNY 1.94 billion, down from CNY 1.99 billion at the end of Q1 2024, indicating a decrease in liquidity[19] - The net cash flow from operating activities for Q1 2025 was a negative CNY 539.04 million, compared to a negative CNY 515.68 million in Q1 2024, showing a worsening cash flow situation[18] - Investment activities generated a net cash outflow of CNY 253.73 million in Q1 2025, contrasting with a net inflow of CNY 426.07 million in Q1 2024, indicating a shift in investment strategy[18] Assets and Liabilities - Total assets at the end of the reporting period were CNY 17,987,487,362, down 2.57% from CNY 18,461,736,241 at the end of the previous year[2] - Total liabilities as of March 31, 2025, were CNY 8,421,793,255, down from CNY 8,926,973,061 at the end of 2024[12] - As of March 31, 2025, total assets were CNY 17,987,487,362, a decrease from CNY 18,461,736,241 at the end of 2024[10] Operating Costs and Expenses - The company reported an increase in operating costs, which significantly impacted the net profit attributable to shareholders[5] - The company reported total operating costs of CNY 1,859,478,004 in Q1 2025, compared to CNY 1,845,326,170 in Q1 2024[14] - The company's management expenses for Q1 2025 were CNY 194,653,403, up from CNY 184,417,276 in Q1 2024[14] - R&D expenses for Q1 2025 were CNY 199.88 million, a decrease from CNY 218.19 million in Q1 2024, representing a decline of approximately 8.5%[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 100,095[7] Business Development - The company signed new AI application contracts in vertical fields totaling CNY 189,000,000, with a year-on-year increase of 54%[9] - In the "AI + healthcare" sector, new AI application contracts amounted to CNY 139,000,000, reflecting a significant year-on-year growth of 211%[9]